Cargando…
Use of granulocyte colony‐stimulating factor in the treatment of methimazole‐induced agranulocytosis: a case report
A comparison of this case to previously published reports suggests that granulocyte colony‐stimulating factor may be associated with improved prognosis in severe antithyroid drug‐induced neutropenia, and that weight‐based doses could be an appropriate strategy.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628249/ https://www.ncbi.nlm.nih.gov/pubmed/29026576 http://dx.doi.org/10.1002/ccr3.1124 |
| Sumario: | A comparison of this case to previously published reports suggests that granulocyte colony‐stimulating factor may be associated with improved prognosis in severe antithyroid drug‐induced neutropenia, and that weight‐based doses could be an appropriate strategy. |
|---|